Search International and National Patent Collections

1. (WO2018036435) HYBRIDOMA CELL STRAIN SCCA1, MONOCLONAL ANTIBODY SECRETED THEREBY, AND APPLICATION OF SAME

Pub. No.:    WO/2018/036435    International Application No.:    PCT/CN2017/098110
Publication Date: Fri Mar 02 00:59:59 CET 2018 International Filing Date: Sat Aug 19 01:59:59 CEST 2017
IPC: C12N 5/20
C07K 16/30
G01N 33/574
G01N 33/577
C12R 1/91
Applicants: RAYBIOTECH, INC. GUANGZHOU
广州瑞博奥生物科技有限公司
Inventors: HUANG, Ruopan
黄若磐
LUO, Shuhong
罗树红
FANG, Jianmin
方建民
ZHANG, Yuming
张玉明
HU, Yang
胡洋
Title: HYBRIDOMA CELL STRAIN SCCA1, MONOCLONAL ANTIBODY SECRETED THEREBY, AND APPLICATION OF SAME
Abstract:
A hybridoma cell strain SCCA1, a monoclonal antibody secreted thereby, and application of same. The collection number of the hybridoma cell strain SCCA1 is CCTCC No: C2016131. The monoclonal antibody is secreted by the hybridoma cell strain SCCA1, and may be used in the preparation of a reagent for detecting a cervical cancer. The monoclonal antibody is highly specific. An in vitro diagnostic kit for detecting the cervical cancer built on the basis of the monoclonal antibody has a high detection speed, uses only a small amount of blood sample, and provides highly sensitive detection results. The in vitro diagnostic kit provides a rapid, specific, and sensitive detecting method for different clinical and practical requirements, and greatly improves cervical cancer monitoring and management.